Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment

• Souleymane Sawadogo ,

  * E-mail: ssawadogo@cdc.gov

  Affiliation Division of Global HIV/AIDS (DGHA), Centers for Disease Control and Prevention (CDC), Windhoek, Namibia

  http://orcid.org/0000-0002-4206-4454

  ⨯
• Boniface Makumbi,

  Affiliation Namibia Institute of Pathology (NIP), Windhoek, Namibia

  ⨯
• Anne Purfield,

  Affiliation Mycotic Disease Branch, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States of America

  ⨯
• Christophine Ndjavera,

  Affiliation Namibia Institute of Pathology (NIP), Windhoek, Namibia

  ⨯
• Gram Mutandi,

  Affiliation Division of Global HIV/AIDS (DGHA), Centers for Disease Control and Prevention (CDC), Windhoek, Namibia

  ⨯
• Andrew Maher,

  Affiliation Global Health Sciences, University of California San Francisco, San Francisco, CA, United States of America

  ⨯
• Francina Kaindjee-Tjituka,

  Affiliation Directorate of Special Programs, Ministry of Health and Social Services, Windhoek, Namibia

  ⨯
• Jonathan E. Kaplan,

  Affiliation Division of Global HIV/AIDS (DGHA), Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States of America

  ⨯
• Benjamin J. Park,

  Affiliation Mycotic Disease Branch, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States of America

  ⨯
• David W. Lowrance

  Affiliation Division of Global HIV/AIDS (DGHA), Centers for Disease Control and Prevention (CDC), Windhoek, Namibia

  ⨯